{"id":"F2014L01012","name":"Therapeutic Goods (Listing) Notice 2014 (No. 3)","slug":"therapeutic-goods-listing-notice-2014-no-3","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":92129,"registerId":"commonwealth-F2014L01012-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2014 (No. 3)","content":"Therapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2014 (No. 3)\n\nI, JOHN SKERRITT, National Manager of the Therapeutic Goods Administration, delegate of the Minister for Health for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:\n\n    preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘iron’ (also known as elemental iron) as a therapeutically active ingredient, subject to the following conditions:\n\n-   the preparations contain a daily dose of not more than 24 mg of iron; and\n-   the primary pack contains not more than 750 mg of iron if the divided preparations contain more than 5 mg of iron per dosage unit; and\n-   the preparations are for oral use only.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.\n\nDated this 24th day of June 2014\n\n(Signed by)\n\nProfessor John Skerritt\n\nDelegate of the Minister for Health","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1791},"content_quality":"ok","complexity_score":3,"scope_assessment":{"changed":false,"description":"The instrument maintains its original narrow scope as a temporary mechanism to require ARTG listing of specific iron preparations pending regulatory amendment."},"complexity_factors":["Conditional pack size limit (750mg cap only applies if individual dosage units exceed 5mg)","Self-executing sunset clause triggered by future amendment to separate Regulations","Cross-reference to specific item in Regulations (Schedule 4, Part 1, Item 3)","Operation under delegated authority (subsection 9A(5) of the Act)"],"plain_english_summary":"This notice temporarily requires low‑dose oral iron supplements to be listed on the Australian Register of Therapeutic Goods (ARTG), ensuring they meet safety and quality oversight. It affects manufacturers and suppliers of these products in Australia and remains in force only until the Therapeutic Goods Regulations are amended to make the requirement permanent."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2014-no-3","history":"/api/acts/therapeutic-goods-listing-notice-2014-no-3/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2014-no-3/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2014-no-3/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2014-no-3/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2014-no-3/documents"}}